# Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

> **NCT00445419** · PHASE1 · COMPLETED · sponsor: **Pevion Biotech Ltd** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **BIOLOGICAL:** PEV2A PEV2B

## Key facts

- **NCT ID:** NCT00445419
- **Lead sponsor:** Pevion Biotech Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00445419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00445419, "Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00445419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*